patients who need general anesthesia with tracheal intubation.
Conditions
Interventions
Intervention 1: Intervention group 1: Patients will receive Etomidate (10 cc ampoules, 2 milligrams per cc, made by Abu Reihan Pharmaceutical Company) in the amount of 0.3 milligrams per kilogram body
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with ASA (American Society of Anesthesiologists) grade:1 or 2 Patients aged 18 to 65 years Patients who need tracheal intubation and general anesthesia
Exclusion criteria
Exclusion criteria: Patients with heart failure disease Patients who are addicted to drugs Patients with airway anomalies Patients with hepatic failure disease Patients with renal failure disease Patients with over 65 years or under 18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure mean in each group. Timepoint: Before intervention and 1, 3, 5 and 10 minutes after laryngoscopy. Method of measurement: Blood pressure manometer.;Diastolic blood pressure mean in each group. Timepoint: Before intervention and 1, 3, 5 and 10 minutes after laryngoscopy. Method of measurement: Blood pressure manometer.;Heart rate mean in each group. Timepoint: Before intervention and 1, 3, 5 and 10 minutes after laryngoscopy. Method of measurement: Heart monitoring device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Arterial oxygen saturation mean in each group. Timepoint: Before intervention and 1, 3, 5 and 10 minutes after laryngoscopy. Method of measurement: Pulse oximeter.;Electrocardiogram ST-T changes relative frequency in each group. Timepoint: Before intervention and 1, 3, 5 and 10 minutes after laryngoscopy. Method of measurement: Electrocardiogram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzim Honarmand
Esfahan University of Medical Sciences
Outcome results
None listed